Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer

Kim Ah Yeong; Kim Chan Kyo; Park Sung Yoon; Park Byung Kwan

首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer

【24h】

Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer

机译：扩散加权成像评估前列腺癌中雄激素剥夺治疗的变化

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE. The objective of our study was to investigate the usefulness of apparent diffusion coefficient (ADC) values in evaluating for therapeutic changes from androgen deprivation therapy (ADT) in prostate cancer patients.

机译：目的。我们研究的目的是研究表观扩散系数（ADC）值在评估前列腺癌患者因雄激素剥夺治疗（ADT）而引起的治疗变化中的作用。

著录项

来源
《AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences》 |2014年第6期|共6页
作者
Kim Ah Yeong; Kim Chan Kyo; Park Sung Yoon; Park Byung Kwan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词
androgen deprivation; biomarker; diffusion-weighted imaging; MRI; prostate cancer;

机译：雄激素剥夺;生物标志物;弥散加权成像;MRI;前列腺癌;

相似文献

外文文献
中文文献
专利

1. Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer [J] . Kim Ah Yeong, Kim Chan Kyo, Park Sung Yoon, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2014,第6期

机译：扩散加权成像评估前列腺癌中雄激素剥夺治疗的变化
2. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer [J] . Davda R., Hughes S., Jones R., Clinical oncology . 2016,第6期

机译：在第一次诊断晚期前列腺癌的化疗 - 革命还是演变？英国Uro-Moycology Group Group US调查的调查结果评估肿瘤学系的肿瘤学家的看法与雄激素剥夺的转移和高风险/局部晚期前列腺癌的雄激素剥夺治疗组合
3. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI [J] . Hoetker Andreas M., Mazaheri Yousef, Zheng Junting, European radiology . 2015,第9期

机译：前列腺癌：使用定量弥散加权和动态对比增强MRI评估雄激素剥夺治疗的效果
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy [O] . Ulrika Björeland, Tufve Nyholm, Joakim Jonsson, 2021

机译：新辅助雄激素剥夺治疗对放疗前前列腺癌磁共振成像特征的影响
7. Chemotherapy at first diagnosis of advanced prostate cancer – revolution or evolution? Findings from a British uro-oncology group UK survey to evaluate oncologists' views on first-line docetaxel in combination with androgen deprivation therapy in castrate-sensitive metastatic and high-risk/locally advanced prostate cancer [O] . Davda, R., Hughes, S., Jones, R., 2016

机译：首次诊断为晚期前列腺癌的化疗 - 革命还是进化？来自英国尿液肿瘤学组英国调查的结果，评估肿瘤学家对一线多西紫杉醇联合雄激素剥夺治疗对去势敏感的转移性和高风险/局部晚期前列腺癌的看法

Diffusion-Weighted Imaging to Evaluate for Changes From Androgen Deprivation Therapy in Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅